Multicentre trials in obstetrics and gynaecology: Smaller explanatory trials are required

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 7, 1996, Pages 599-602

  Grant, John M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; EDITORIAL; GYNECOLOGY; HUMAN; MULTICENTER STUDY; OBSTETRICS; PRIORITY JOURNAL;

ASPIRIN; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MULTICENTER STUDIES; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS;

EID: 0030001167     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09823.x     Document Type: Editorial

References (36)

1. Cochrane AL. One Man's Medicine. The British Medical Journal, London: 1989.
2. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ 1948; 2: 769–782.
3. Francis T, Korns R, Voight R et al. An evaluation of the 1954 poliomyelitis vaccine trials. Am J Public Health 1955; 45: 1–63.
4. Meir P. The biggest public health experiment ever: the 1954 field trial of the Salk poliomyelitis vaccine. In Tanur, JM, editors. Statistics: A Guide to the Unknown. 1972; 2–13.
5. Gruppo Italiano per Io Studio della Streptochinasi nell'infarcto miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397–402.
6. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute mycardial infarction: ISIS-2. Lancet 1988; 1: 349–360.
7. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. A randomised trial of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected myocardial infarction. Lancet 1992; 339: 753–770.
8. LATE Study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759–766.
9. EMERAS (Estudaio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993; 342: 767–772.
10. Collins R. Antiplatelet agents for IUGR and pre-eclampsia. Pregnancy and Childbirth Module. In Enkin MW, Keirse MJNC, Renfrew M J, Neilson, JP, editors. Cochrane Database of Systematic Reviews: Review No. 04000 4th May 1994. Published through Cochrane Updates on Disk, Oxford: Update Software, 1994, Disk Issue 1.
11. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985; 1: 840–842.
12. Wallenburg HCS, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1–3.
13. Railton A, Davey DA. Aspirin and dipyrimadole in the prevention of pre-eclampsia: effect on plasma 6 keto PGF1 alpha and TxB2 and clinical outcome of pregnancy. Proceedings of the First European Congress on Prostaglandins in Reproduction, Vienna, Austria. 1988; 48.
14. Benigni A, Gregorini G, Frusca T et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357–362.
15. Dekker GA. Prediction and prevention of pregnancy-induced hypertensive disorders: a clinical and pathophysiological study. [MD thesis] Rotterdam, The Netherlands: University Medical School, 1989.
16. Schiff E, Peleg E, Goldenberg M et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351–356.
17. Sibai BM, Mirro R, Chesney CM, Leffler C. Low dose aspirin in pregnancy. Obstet Gynecol 1989; 74: 551–557.
18. Azar R, Turpin D. Effect of antiplatelet therapy in women at high risk for pregnancy-induced hypertension. Proceedings of the 7th World Congress of Hypertension in Pregnancy, Perugia, Italy. 1990; 251.
19. McParland P, Pearce JM, Chamberlain GVP. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990; 1: 1552–1555.
20. North RA, Fairley KF, Kloss M, Ihle B, Kincaid-Smith P. Prevention of pre-eclampsia in women with renal disease. Proceedings of the 7th World Congress of Hypertension in Pregnancy, Perugia, Italy. 1990; 75.
21. Roberts CS, Beeson JG. Low-dose aspirin in the prevention of preeclampsia in nulliparas. Preliminary results of a prospective, placebo-controlled, double-blind study. Proceedings of the 10th Annual Meeting of the Society of Perinatal Obstetricians, Houston, Texas, USA. 1990; 89.
22. Ramaiya CP. Low dosage of aspirin in prevention of pregnancy induced hypertension (PIH) in primigravidae at Muhimbili Medical Centre, Dar es Salaam [MD thesis] University of Dar es Salaam, Ethiopa, 1992.
23. Uzan M, Beaufils M, Breart G, Bazin B, Capitant C, Paris J, Uzan S. Prevention of pre-eclampsia with low-dose aspirin: results of the EPREDA trial. J Perinat Med 1990; 18 (Suppl): 116.
24. Viinikka L, Hartikainen-Sorri AL, Lumme R, Hiilesmaa V, Ylikorkala O. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. Br J Obstet Gynaecol 1993; 100: 809–815.
25. Hauth J, Goldenberg R, Philips J, Copper R, DuBard M, Cutter G. Low-dose aspirin therapy to prevent pre-eclampsia: safety considerations. Am J Obstet Gynecol 1993; 168 (Suppl): 389.
26. Parazzini F, Benedetto C, Frusca T et al. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 1993; 341: 396–400.
27. Sibai BM, Caritas SN, Thom E et al. The National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329: 1213–1218.
28. CLASP (Collaborative Low-Dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–629.
29. ECPPA (Estudo Colaborativo para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynuecol 1996; 103: 39–47.
30. Egger M, Smith GD. Misleading meta-analysis. BMJ 1995; 310: 752–754.
31. Yusuf S, Flather M. Magnesium in acute myocardial infarction. BMJ 1995; 210: 751–752.
32. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–685.
33. Bower SJ, Harrington KF, Schuchter K, McGirr C, Campbell S. Prediction of pre-eclampsia by abnormal uterine doppler ultrasound and modified by aspirin. Br J Obstet Gynaecol 1996; 103: 625–629.
34. Where next for prophylaxis against pre-eclampsia? [Report of a RCOG workshop: Royal College of Obstetricians and Gynaecologists, London, 15 December 1994]. Br J Obstet Gynaecol 1996; 103: 603–607.
35. MRC/RCOG Working Party. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993; 100: 516–523.
36. Eclampsia Collaborative Trial Group. Which anticonvulsant for eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995; 345: 1455–1463.